Brad Wertz

Brad Wertz is the current CEO and Chairman at GenomOncology. Brad has over 15 years of experience in the healthcare industry, including previous positions as President & COO at Rosetta and COO at Brulant. Brad has also served as a co-founder at Xteric Technology Group. Brad holds a bachelor's degree in Business Administration from the University of Michigan.

Some direct reports include Justin Yeakley - VP, Product Development, Ian Maurer - Chief Technology Officer, and Joe McCrone - SVP, Client Services.